WINT stock forecast
Our latest prediction for Windtree Therapeutics, Inc.'s stock price was made on the Feb. 18, 2020 when the stock price was at 4.10$.
In the short term (2weeks), WINT's stock price should outperform the market by 1.04%. During that period the price should oscillate between -11.19% and +15.40%.
In the medium term (3months), WINT's stock price should underperform the market by -8.48%. During that period the price should oscillate between -45.99% and +38.40%.Get email alerts
Create a solid portfolio with WINT
About Windtree Therapeutics, Inc.
Windtree Therapeutics, Inc. engages in the manufacture and development of products for infants and respiratory diseases. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -2.39$ per share.
The book value per share is -8.31$
Three months stock forecastFeb. 18, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|